OncLive® is proud to present the National Fellows Forum: Lung Cancer. This forum provides the opportunity for fellows to share their current research and education with peers and role models within the oncology community. Our board of esteemed faculty will review each submission and select 15 fellows to attend the forum, held the day before the IASLC | ASCO North America Conference on Lung Cancer (NACLC). This forum is designed for fellows already attending NACLC.
BENEFITS: ✅ $350 stipend for your participation
🤝 Unparalleled Networking – Connect with renowned faculty and peers in the field
Oncology fellows are invited to submit their research abstract for consideration by
Sunday, November 8, 2026, at 11:59 PM ET.
- All abstracts must be submitted online, in PDF version.
- Your abstract should be a short description of your research/work in lung cancer, containing all the elements necessary to define your goals and results to the reader.
- Authors will be required to disclose all financial relationships helping to ensure quality and unbiased presentations
- All categories pertaining to the subject matter are welcomed. Abstracts are for any project in which there has been data analyzed and not for a presentation of an ongoing project without analyzable data or with results pending.
Note: Abstract submissions must reflect completed research. Submissions of previously presented research are permitted.
Our board of faculty will evaluate the abstracts based on the following criteria: novelty of the research, significance of the findings, relevance to lung cancer, and clarity. Incomplete abstracts will not be accepted.
Notification of acceptance, or regret, will be delivered via e-mail to fellows by the end of November. All 15 selected fellows will give an oral presentation in small groups of 5, with about 20 minutes each for the presentation and faculty feedback.
Abstract Format
- The title of the abstract should be brief, objectively describing the study. Do not use non-standard abbreviations and commercial names (generic names only).
- Capitalize only the first word and any proper nouns.
- Only one submission per fellow.
- Abstracts are permitted to have one figure or table included in submission
- Abstracts limited to 2500 characters (abstract body, including spaces).
- Abstracts should be structured in such a way as to include the following 4 sections:
- Objectives -- What was the intent or goal of the study? What did you want to learn?
- Methods -- What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?
- Results -- What were the findings?
- Conclusions -- What do the findings mean?
Abstract QuestionsPlease submit any questions pertaining to submissions to Sean Gallagher sgallagher@mjhlifesciences.com.
